[1] JAMAL S M,BELSHAM G J.Foot-and-mouth disease:Past,present and future[J].Vet Res,2013,44:116.
[2] DOMINGO E,ESCARMÍS C,BARANOWSKI E,et al.Evolution of foot-and-mouth disease virus[J].Virus Res,2003,91(1):47-63.
[3] KNOWLES N J,SAMUEL A R.Molecular epidemiology of foot-and-mouth disease virus[J].Virus Res,2003,91(1):65-80.
[4] GRUBMAN M J,BAXT B.Foot-and-mouth disease[J].Clin Microbiol Rev,2004,17(2):465-493.
[5] BELSHAM G J.Distinctive features of foot-and-mouth disease virus,a member of the picornavirus family;Aspects of virus protein synthesis,protein processing and structure[J].Prog Biophys Mol Biol,1993,60(3):241-260.
[6] VOUGIOUKALAKI M,KANELLIS D C,GKOUSKOU K,et al.Tpl2 kinase signal transduction in inflammation and cancer[J].Cancer Lett,2011,304(2):80-89.
[7] PLESCHKA S.RNA viruses and the mitogenic Raf/MEK/ERK signal transduction cascade[J].Biol Chem,2008,389(10):1273-1282.
[8] DAS S,CHO J,LAMBERTZ I,et al.Tpl2/cot signals activate ERK,JNK,and NF-κB in a cell-type and stimulus-specific manner[J].J Biol Chem,2005,280(25):23748-23757.
[9] WATERFIELD M R,ZHANG M Y,NORMAN L P,et al.NF-κB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase[J].Mol Cell,2003,11(3):685-694.
[10] DUMITRU C D,CECI J D,TSATSANIS C,et al.TNF-α induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway[J].Cell,2000,103(7):1071-1083.
[11] ELIOPOULOS A G,WANG C C,DUMITRU C D,et al.Tpl2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40[J].EMBO J,2003,22(15):3855-3864.
[12] ELIOPOULOS A G,DUMITRU C D,WANG C C,et al.Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals[J].EMBO J,2002,21(18):4831-4840.
[13] CHIARIELLO M,MARINISSEN M J,GUTKIND J S.Multiple mitogen-activated protein kinase signaling pathways connect the cot oncoprotein to the c-jun promoter and to cellular transformation[J].Mol Cell Biol,2000,20(5):1747-1758.
[14] XIAO N M,EIDENSCHENK C,KREBS P,et al.The Tpl2 mutation Sluggish impairs type I IFN production and increases susceptibility to group B streptococcal disease[J].J Immunol,2009,183(12):7975-7983.
[15] MCNAB F W,EWBANK J,RAJSBAUM R,et al.TPL-2-ERK1/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production[J].J Immunol, 2013, 191(4):1732-1743.
[16] KURIAKOSE T,TRIPP R A,WATFORD W T.Tumor progression locus 2 promotes induction of IFNλ,interferon stimulated genes and antigen-specific CD8+ T cell responses and protects against influenza virus[J].PLoS Pathog, 2015, 11(8):e1005038.
[17] MIELKE L A,ELKINS K L,WEI L,et al.Tumor progression locus 2(Map3k8) is critical for host defense against Listeria monocytogenes and IL-1β production[J].J Immunol, 2009, 183(12):7984-7993.
[18] KAKIMOTO K,MUSIKACHAROEN T,CHIBA N,et al.Cot/Tpl2 regulates IL-23 p19 expression in LPS-stimulated macrophages through ERK activation[J].J Physiol Biochem, 2010, 66(1):47-53.
[19] SELLERS R F,BENNETT J H,MOWAT G N,et al.Some factors affecting interferon production by foot-and-mouth disease virus in bovine tissue cultures[J].Arch Gesamte Virusforsch, 1968, 23(1-2):1-11.
[20] CHINSANGARAM J,PICCONE M E,GRUBMAN M J.Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon[J].J Virol,1999,73(12):9891-9898.
[21] DE LOS SANTOS T, DE AVILA BOTTON S, WEIBLEN R, et al.The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response[J].J Virol, 2006,80(4):1906-1914.
[22] WANG D, FANG L R, LI K, et al. Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling[J].J Virol,2012,86(17):9311-9322.
[23] DU Y J, BI J S,LIU J Y, et al. 3Cpro of foot-and-mouth disease virus antagonizes the interferon signaling pathway by blocking STAT1/STAT2 nuclear translocation[J].J Virol,2014,88(9):4908-4920.
[24] LI C T, ZHU Z X, DU X L, et al. Foot-and-mouth disease virus induces lysosomal degradation of host protein kinase PKR by 3C proteinase to facilitate virus replication[J].Virology, 2017, 509:222-231.
[25] ZHU Z X, WANG G Q, YANG F, et al.Foot-and-mouth disease virus viroporin 2B antagonizes RIG-I-mediated antiviral effects by inhibition of its protein expression[J].J Virol, 2016, 90(24):11106-11121.
[26] LI D,LEI C Q,XU Z S,et al.Foot-and-mouth disease virus non-structural protein 3A inhibits the interferon-β signaling pathway[J].Sci Rep,2016,6:21888.
[27] MENON M B,GAESTEL M.TPL2 meets p38MAPK:Emergence of a novel positive feedback loop in inflammation[J].Biochem J,2016,473(19):2995-2999.
[28] KAISER F,COOK D,PAPOUTSOPOULOU S,et al.TPL-2 negatively regulates interferon-β production in macrophages and myeloid dendritic cells[J].J Exp Med, 2009, 206(9):1863-1871.
[29] WATFORD W T,HISSONG B D,DURANT L R,et al.Tpl2 kinase regulates T cell interferon-γ production and host resistance to Toxoplasma gondii[J].J Exp Med, 2008, 205(12):2803-2812.
[30] TSUBOTA A,MOGUSHI K,AIZAKI H,et al.Involvement of MAP3K8 and miR-17-5p in poor virologic response to interferon-based combination therapy for chronic hepatitis C[J].PLoS One, 2014, 9(5):e97078. |